• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • Experts on Demand
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2023: $130 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

30-Country IVD Market Atlas (In Vitro Diagnostic Markets for US, China, Germany, UK, Saudi Arabia, India, UAE, France, Vietnam, Turkey and 20 Other Countries)

$5,000.00 – $10,000.00

Clear
SKU: 23-701 Categories: Diagnostics Market Research, in vitro diagnostic, IVD Tags: blood banking, chemistry, Coagulation, COVID-19, Critical Care, cytology, Diagnostics, global market, glucose, Hematology, histology, Immunoassays, in vitro diagnostics, In Vitro Diagnostics (IVD) Market, ivd, molecular Pages: 71
  • Description
  • Table of Contents
  • Latest reports

Description

In Vitro Diagnostics is a global market estimated to consist of over $120 billion. With less than half that revenue earned in the United States, an assessment of regional and country IVD markets is needed for successful business planning.  Kalorama’s 30 Country IVD Market Atlas report is designed to provide you with international market detail at the country-level to help improve your forecast modeling and planning.

Whether you need Latin America, Middle East, APAC or Eastern Europe, this report has country-level markets and forecasts.

If you need geographical IVD markets by country from an authoritative source, this report also provides that. Up to date as of Q1 2023, this report is designed to cover every significant world IVD market.

  • One Report Covering 30 Countries
  • Reliable Estimates From an IVD-Focused Analyst Team  (The Authors of Kalorama’s Worldwide Market for In Vitro Diagnostics)
  • Sizing for 19 Important IVD Market Segments
  • Segments Estimated for Each Country
  • Lab-Based and POC Segments for Many Disease Areas
  • Designed to Align with Other Kalorama Reports
  • Forecasts in Revenue to 2027 for Each Segment
  • CAGRS for Each Segment and Country
  • Updated Quarterly (4 updates annually) to Reflect Market Changes
  • Analyst Notes for Significant Developments
  • Definitions and Descriptions of Tests
  • Over 2800 Data Points

Over two decades of publishing in vitro diagnostic market research, Kalorama Information has heard from customers: IVD is a global industry, growth is global and our customers want more geographic coverage.  As a result, we are offering geographic research and analysis focused at the country, rather than regional level in our 30 Country In Vitro Diagnostics (IVD) Market Atlas.  A quarterly-updated, 30-country market research report with the major IVD segments forecasted out five years.

To replicate the 2800+ data points in the IVD Market Atlas, you’d need to buy dozens of other companies market research studies.

This quarterly updated report contains IVD markets aligned to Kalorama’s expert global estimates in our Worldwide Market for In Vitro Diagnostics, segmented for 30 important country markets and for 19 key test segments.


Countries covered in the IVD Market Atlas include:

  • Australia
  • Austria
  • Belgium
  • Brazil
  • Canada
  • Chile
  • China
  • Egypt
  • France
  • Germany
  • India
  • Indonesia
  • Italy
  • Japan
  • Mexico
  • Netherlands
  • Poland
  • Romania
  • Russia
  • Saudi Arabia
  • South Africa
  • South Korea
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom
  • United States
  • Vietnam

Market researchers will tend to sell reports for each of these countries, rather than combine in one report.  For Kalorama, our mission is different.  We seek to keep companies informed with useful references when they need it, rather than publish hundreds of reports a year.     The IVD Market Atlas reflects this mission. 

It’s important to note that for each of these countries, there is an overall IVD market estimate and then, the most important market segments are broken out.  These include:

  • Blood Bank Immunoassays
  • Blood Bank Molecular (NAT)
  • Clinical Chemistry
  • Coagulation
  • COVID-19
  • Critical Care
  • FOB
  • Glucose
  • Hematology
  • Histology/Cytology
  • ID/AST Microbiology
  • Immunoassays
  • Immunoassays, Micro
  • Molecular, Micro
  • Molecular, Others
  • Overall Country IVD
  • Point of Care
  • POC Infectious Disease
  • Pregnancy Testing

While these are not every segment possible, they are the most important [most searched for/requested and largest] IVD market segments.

The report is updated every 3 months.  Why?  This is to keep up with market changes.  It was once the case that the IVD market didn’t change rapidly.  COVID-19, international changes, M&A activity, new products, point of care trends and regulatory activity have all worked together to change that.  While there may not be substantial change in markets between one quarter and another, the report will catch segment changes, and you will always have an updated data set for your business planning.

Those who subscribe will be placed on our Knowledge Center product and will receive quarterly updates.

FULL REPORT CONTENTS

U.S. IVD Market

U.S. IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)

Germany IVD Market

Germany IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)

Japan IVD Market

Japan IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)

China IVD Market

China IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)

France IVD Market

France IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)

United Kingdom IVD Market

United Kingdom IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)

Italy IVD Market

Italy IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)

Canada IVD Market

Canada IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)

Spain IVD Market

Spain IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)

Australia IVD Market

Australia IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)

Brazil IVD Market

Brazil IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)

Russia IVD Market

Russia IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)

India IVD Market

India IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)

Switzerland IVD Market

Switzerland IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)

Netherlands IVD Market

Netherlands IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)

Poland IVD Market

Poland IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)

Turkey IVD Market

Turkey IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)

Sweden IVD Market

Sweden IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)

Belgium IVD Market

Belgium IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)

Mexico IVD Market

Mexico IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)

Austria IVD Market

Austria IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)

Saudi Arabia IVD Market

Saudi Arabia IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)

South Korea IVD Market

South Korea IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)

Romania IVD Market

Romania IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)

Egypt IVD Market

Table 26-1: Egypt IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)

Indonesia IVD Market

Indonesia IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)

Chile IVD Market

Chile IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)

South Africa IVD Market

South Africa IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)

United Arab Emirates IVD

United Arab Emirates IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)

Vietnam IVD Market

Vietnam IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)

Table of Contents

Chapter One: Worldwide IVD Market

IVD Market Demand and Growth

Scope and Methodology

Market Segmentation

Country Atlas Scope

  • Table 1-1: Key Interest Countries (30-Country Atlas) for IVD Markets, 2022

Chapter Two: United States

U.S. IVD Market Overview

  • Table 2-1: U.S. IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)

Chapter Three: Germany

Germany IVD Market Overview

  • Table 3-1: Germany IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)

Chapter Four: Japan

Japan IVD Market Overview

  • Table 4-1: Japan IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)

Chapter Five: China

China IVD Market Overview

  • Table 5-1: China IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)

Chapter Six: France

France IVD Market Overview

  • Table 6-1: France IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)

Chapter Seven: United Kingdom

United Kingdom IVD Market Overview

  • Table 7-1: United Kingdom IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)

Chapter Eight: Italy

Italy IVD Market Overview

  • Table 8-1: Italy IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)

Chapter Nine: Canada

Canada IVD Market Overview

  • Table 9-1: Canada IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)

Chapter Ten: Spain

Spain IVD Market Overview

  • Table 10-1: Spain IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)

Chapter Eleven: Australia

Australia IVD Market Overview

  • Table 11-1: Australia IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)

Chapter Twelve: Brazil

Brazil IVD Market Overview

  • Table 12-1: Brazil IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)

Chapter Thirteen: Russia

Russia IVD Market Overview

  • Table 13-1: Russia IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)

Chapter Fourteen: India

India IVD Market Overview

  • Table 14-1: India IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)

Chapter Fifteen: Switzerland

Switzerland IVD Market Overview

  • Table 15-1: Switzerland IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)

Chapter Sixteen: Netherlands

Netherlands IVD Market Overview

  • Table 16-1: Netherlands IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)

Chapter Seventeen: Poland

Poland IVD Market Overview

  • Table 17-1: Poland IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)

Chapter Eighteen: Turkey

Turkey IVD Market Overview

  • Table 18-1: Turkey IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)

Chapter Nineteen: Sweden

Sweden IVD Market Overview

  • Table 19-1: Sweden IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)

Chapter Twenty: Belgium

Belgium IVD Market Overview

  • Table 20-1: Belgium IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)

Chapter Twenty-One: Mexico

Mexico IVD Market Overview

  • Table 21-1: Mexico IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)

Chapter Twenty-Two: Austria

Austria IVD Market Overview

  • Table 22-1: Austria IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)

Chapter Twenty-Three: Saudi Arabia

Saudi Arabia IVD Market Overview

  • Table 23-1: Saudi Arabia IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)

Chapter Twenty-Four: South Korea

South Korea IVD Market Overview

  • Table 24-1: South Korea IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)

Chapter Twenty-Five: Romania

Romania IVD Market Overview

  • Table 25-1: Romania IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)

Chapter Twenty-Six: Egypt

Egypt IVD Market Overview

  • Table 26-1: Egypt IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)

Chapter Twenty-Seven: Indonesia

Indonesia IVD Market Overview

  • Table 27-1: Indonesia IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)

Chapter Twenty-Eight: Chile

Chile IVD Market Overview

  • Table 28-1: Chile IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)

Chapter Twenty-Nine: South Africa

South Africa IVD Market Overview

  • Table 29-1: South Africa IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)

Chapter Thirty: United Arab Emirates

United Arab Emirates IVD Overview

  • Table 30-1: United Arab Emirates IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)

Chapter Thirty-One: Vietnam

Vietnam IVD Market Overview

  • Table 31-1: Vietnam IVD Market by Segment (Blood Bank Screening – Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays – Micro, Immunoassays – Non-Micro, Microbiology – ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2022-2027 (in millions $)
    In Vitro Diagnostic (IVD) Procedure Volumes (Chemistry, Immunoassays, Hematology, Microbiology, Histology, Point of Care), 2023-2028
    September 22, 2023
    The Worldwide Market for In Vitro Diagnostic Tests, 16th Edition
    August 24, 2023
    30-Country IVD Market Atlas (In Vitro Diagnostic Markets for US, China, Germany, UK, Saudi Arabia, India, UAE, France, Vietnam, Turkey and 20 Other Countries)
    August 21, 2023
    At-Home Diagnostic Testing Markets and Trends (COVID-19, FOB, Glucose, HIV and Other Tests), 2023
    June 6, 2023

Related products

  • Placeholder image

    Blood – The Worldwide Market for Blood Products, Blood Testing, Blood Equipment, and Synthetic Blood Products

    $1,995.00 – $7,800.00
  • Placeholder image

    Molecular Diagnostics for Inherited Disease Testing: Testing volume, cost per test, and market potential

    $995.00 – $1,990.00
  • Placeholder image

    Clinical Diagnostics in China – Market Sector Analyses and Participant Directory

    $4,995.00 – $9,990.00
  • Placeholder image

    Medical Imaging Markets, Volume III – Ultrasound

    $1,200.00 – $5,990.00

Contact Us

  •  Email Us: Customer Service

  •  Phone (US):  703-778-3080

  •  Fax:  703-778-3081

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • How Globalization and Climate Change Impact COVID-19 and the IVD Market September 20, 2023
  • IVD Trends 2023-2028: Emerging Growth Markets in Asia, Latin America, and the Middle East September 15, 2023
  • Worldwide IVD: 8 Key Trends to Watch in $106 Billion Market September 6, 2023
  • The Wide-Reaching Potential of Artificial Intelligence in Healthcare August 28, 2023
  • IVD for Pets: A $2.7 Billion Global Market July 24, 2023

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
Out of Pocket Spending in Healthcare (Pharmaceuticals, Surgeries, Tests, Electives,... The Worldwide Market for In Vitro Diagnostic Tests, 16th Edition
Scroll to top